TobraDex is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Tobramycin; Dexamethasone.
Product ID | 21695-203_330ac1f7-d583-454d-96bf-37c5af31a369 |
NDC | 21695-203 |
Product Type | Human Prescription Drug |
Proprietary Name | TobraDex |
Generic Name | Tobramycin And Dexamethasone |
Dosage Form | Suspension |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1988-08-18 |
Marketing Category | NDA / NDA |
Application Number | NDA050592 |
Labeler Name | Rebel Distributors Corp |
Substance Name | TOBRAMYCIN; DEXAMETHASONE |
Active Ingredient Strength | 3 mg/mL; mg/mL |
Pharm Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1988-08-18 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050592 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1988-08-18 |
Inactivation Date | 2019-09-24 |
Ingredient | Strength |
---|---|
TOBRAMYCIN | 3 mg/mL |
SPL SET ID: | 330ac1f7-d583-454d-96bf-37c5af31a369 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0065-0647 | TobraDex | tobramycin and dexamethasone |
0065-0648 | TobraDex | tobramycin and dexamethasone |
0078-0876 | TobraDex | tobramycin and dexamethasone |
0078-0953 | TobraDex | tobramycin and dexamethasone |
21695-203 | TobraDex | tobramycin and dexamethasone |
21695-628 | TobraDex | tobramycin and dexamethasone |
0574-4031 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
21695-416 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
24208-295 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
50090-1135 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
50090-1893 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
50090-1914 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
52959-984 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
55700-915 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
61314-647 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
63629-9570 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
63629-9571 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
63629-9572 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
68071-1655 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
68071-1821 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
68071-2418 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
68071-2772 | TOBRAMYCIN AND DEXAMETHASONE | tobramycin and dexamethasone |
68071-4203 | Tobramycin and Dexamethasone | Tobramycin and Dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() TOBRADEX 74503378 1897276 Live/Registered |
NOVARTIS AG 1994-03-18 |
![]() TOBRADEX 73631951 1444831 Dead/Cancelled |
ALCON LABORATORIES, INC. 1986-11-24 |